Novel computational approaches to polypharmacology as a means to define responses to individual drugs
- PMID: 22017683
- DOI: 10.1146/annurev-pharmtox-010611-134630
Novel computational approaches to polypharmacology as a means to define responses to individual drugs
Abstract
Polypharmacology, which focuses on designing therapeutics to target multiple receptors, has emerged as a new paradigm in drug discovery. Polypharmacological effects are an attribute of most, if not all, drug molecules. The efficacy and toxicity of drugs, whether designed as single- or multitarget therapeutics, result from complex interactions between pharmacodynamic, pharmacokinetic, genetic, epigenetic, and environmental factors. Ultimately, to predict a drug response phenotype, it is necessary to understand the change in information flow through cellular networks resulting from dynamic drug-target interactions and the impact that this has on the complete biological system. Although such is a future objective, we review recent progress and challenges in computational techniques that enable the prediction and analysis of in vitro and in vivo drug-response phenotypes.
Similar articles
-
The role of fragment-based and computational methods in polypharmacology.Drug Discov Today. 2012 Jan;17(1-2):23-34. doi: 10.1016/j.drudis.2011.08.002. Epub 2011 Aug 16. Drug Discov Today. 2012. PMID: 21864710 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Using quantitative systems pharmacology for novel drug discovery.Expert Opin Drug Discov. 2015 Dec;10(12):1315-31. doi: 10.1517/17460441.2015.1082543. Epub 2015 Aug 25. Expert Opin Drug Discov. 2015. PMID: 26328768 Review.
-
In silico methods to address polypharmacology: current status, applications and future perspectives.Drug Discov Today. 2016 Feb;21(2):288-98. doi: 10.1016/j.drudis.2015.12.007. Epub 2015 Dec 29. Drug Discov Today. 2016. PMID: 26743596 Review.
-
Network pharmacology: the next paradigm in drug discovery.Nat Chem Biol. 2008 Nov;4(11):682-90. doi: 10.1038/nchembio.118. Nat Chem Biol. 2008. PMID: 18936753 Review.
Cited by
-
How promiscuous are pharmaceutically relevant compounds? A data-driven assessment.AAPS J. 2013 Jan;15(1):104-11. doi: 10.1208/s12248-012-9421-y. Epub 2012 Oct 23. AAPS J. 2013. PMID: 23090085 Free PMC article.
-
Rule-based multi-scale simulation for drug effect pathway analysis.BMC Med Inform Decis Mak. 2013;13 Suppl 1(Suppl 1):S4. doi: 10.1186/1472-6947-13-S1-S4. Epub 2013 Apr 5. BMC Med Inform Decis Mak. 2013. PMID: 23566173 Free PMC article.
-
The Pharmacorank Search Tool for the Retrieval of Prioritized Protein Drug Targets and Drug Repositioning Candidates According to Selected Diseases.Biomolecules. 2022 Oct 26;12(11):1559. doi: 10.3390/biom12111559. Biomolecules. 2022. PMID: 36358909 Free PMC article.
-
FacPad: Bayesian sparse factor modeling for the inference of pathways responsive to drug treatment.Bioinformatics. 2012 Oct 15;28(20):2662-70. doi: 10.1093/bioinformatics/bts502. Epub 2012 Aug 24. Bioinformatics. 2012. PMID: 22923307 Free PMC article.
-
Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.Drug Des Devel Ther. 2013 Jun 17;7:449-75. doi: 10.2147/DDDT.S43964. Print 2013. Drug Des Devel Ther. 2013. PMID: 23818757 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources